Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-02-15

Clinical Trial Update: Behavioural Addictions Occurring During a Dopaminergic Treatment Prescribe Under Parkinson's Disease: Study of the Psychopathological, Neurological, Pharmacokinetic and Genetic Profiles [Phase 4]

View source ↗

Summary

Phase 4 trial investigating behavioural addictions that occur during dopaminergic therapy in Parkinson's disease, examining psychopathological, neurological, ph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Nantes University Hospital | Conditions: Parkinson's Disease, Secondary Behavioural Addiction | Phase 4 | Status: COMPLETED